<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04150302</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02034-53</org_study_id>
    <nct_id>NCT04150302</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Questionnaire to Measure the Impact of SBS and Its Treatments on Patients' Lives</brief_title>
  <acronym>ARTEMIS_GC</acronym>
  <official_title>Development and Validation of a Questionnaire to Measure the Impact of Short Bowel Syndrome (SBS) and Its Treatments on Patients' Lives</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beaujon Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Société Francophone Nutrition Clinique et Métabolisme</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Today, patients express a very strong need to take into account the consequences of their
      disease and its treatments in their therapeutic follow-up. It is therefore essential to
      better understand the needs, expectations and values of patients with SBS in order to better
      understand the impact of the disease on their lives, and thus improve the conditions for
      medical, social, psychological and technical care. The clinical expertise of health
      professionals and meetings with patient associations demonstrate the major gap between the
      parameters taken into account by physician to evaluate the evolution of the SBS and the
      day-to-day experience of the disease perceived by the patient.

      The objective of the ARTEMIS-GC study is to develop and validate an instrument to measure the
      impact of SBS and its treatments on daily life from the perspective of patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Scale calibration of the new developped questionnaire</measure>
    <time_frame>about 30 minutes</time_frame>
    <description>Calibration measure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Structure of the new developped questionnaire</measure>
    <time_frame>about 30 minutes</time_frame>
    <description>Structure identification</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Convergence proprieties of the new developped questionnaire</measure>
    <time_frame>about 30 minutes</time_frame>
    <description>Convergence evaluation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reproducibility of the new developped questionnaire</measure>
    <time_frame>Up to 8 days</time_frame>
    <description>Test of reproducibility</description>
  </primary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>SBS - Short Bowel Syndrome</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exploratory interviews</intervention_name>
    <description>Exploratory interviews to generate an interview guide</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Semi-directive interviews</intervention_name>
    <description>Semi-directive interviews to collect qualitative data that will be used for questionnaire item generation</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Delphi Process</intervention_name>
    <description>Cotation of newly developed items pertinence on a 4 points likert scale.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Think aloud interviews</intervention_name>
    <description>Debriefing session for the newly developed items: final possibility to adjust the tool before validating the psychometric proprieties of the questionnaire.</description>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychometric validation</intervention_name>
    <description>Psychometric properties study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years with SBS for more than 6 months and returned home for at least 3
        months.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with SBS defined by a hail length remaining in post-duodenal &lt; 2 meters

          -  Patients with intestinal insufficiency, i.e. chronic malabsorption requiring energetic
             and/or hydro-electrolytic intravenous support for more than 6 months

          -  Patients with a period of at least 6 months after the establishment of the SBS

          -  Patients who has already had a return home after the establishment of the SBS for a
             period of at least 3 months

        Exclusion Criteria:

          -  Patients with intestinal insufficiency but with a cause other than SBS

          -  Lack of understanding of the study

          -  Not speaking French
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laetitia Ricci, PhD</last_name>
    <phone>0033383852092</phone>
    <email>l.ricci@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Francisca Joly, MD, PhD</last_name>
    <email>francisca.joly@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beaujon Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Francisca Joly, MD Pr</last_name>
      <email>francisca.joly@bjn.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 23, 2019</study_first_submitted>
  <study_first_submitted_qc>October 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2019</study_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Short Bowel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

